[MARKET ANALYSIS] European bourses mixed, while Semis slide as Anthropic pushes for slower AI development

Episodes of this kind, where a prominent industry voice questions the pace of AI buildout, have historically produced sharp but often short-lived drawdowns in the high-beta AI supply chain names, memory and equipment makers first, since the selling runs through positioning and multiple compression rather than through any visible change to hyperscaler spending plans. The distinction that matters is between rhetoric and guidance: sustained repricing in this complex has tended to require an actual capex cut or order cancellation from a buyer, not caution from a developer whose own commercial interest arguably runs the other way. The pharma tape is the classic idiosyncratic offset, with single-trial readouts moving individual names in both directions and defensives catching a bid while cyclicals soften, a rotation pattern familiar from past risk-off Mondays. The near-term tells are whether the semi weakness broadens into software and the wider AI trade or stays contained to the capex-levered names, and whether US cash trade confirms the futures signal. With a rate decision due this week, the precedent in comparable weeks is that macro event risk caps follow-through in either direction until the policy outcome and the accompanying communication are known.